after today, an advisory panel voted to approve it. >>the to do list covid-19 vaccine study was conducted on more than 43,000 participants age 16 and older those doses we're given 3 weeks apart and participants were monitored throughout the whole study for side effects common side effects include redness swelling and pain at the injection site new or worsening joint or muscle pain diarrhea vomiting, fever, fatigue headaches. and chills. a small number of participants developed a bell's palsy but there was really not enough data link you get to the actual backseat all right so while this is a monumental step in our fight against the pandemic there's still a lot of work left to be done in so many questions. >>that still remain about the vaccine little earlier today we took to social media to see if you the viewers had many questions you want answered so we actually got a lot of responses and to help out answer some of those questions we're joined now by doctor peter chin, hong an infectious disease expert from ucsf doctor. i thank you ag

the cdc advisory panel -- the cdc advisory panel is going to meet on taensunday, whether to recommend>> these are two committees and some of this is overlapping, wolf. the cdc advisory committee, acip, they have scheduled meeting together. they were the ones who sort of made these recommendations of health care workers and people in long-term care musilt somebody be at the front of the line in the first phase of the vaccine distribution. the fda we don't know when they're going to meet but i thought it was going to be very soon. it could be any time over the next few day, but i did talk to stephen hahn, the commissioner of the fda a few days ago. and he gave me the impression it was going to happen as soon as possible. >> dr. frieden, you used to run the cdc so you're very familiar with the process. i'm now told the advisory committee go to the full fda. they will presumably approve it, and then the final step in all of this before it's released to the public will be on sunday when the centers for disease control and prevention is expect to vote and presumably approve it. but walk us

an fda us government advisory panel has endorsed pfizer's coronavirus vaccine. appened just before we came on air or 3 o'clock and this panel voted that pfizer's covid-19 vaccine. the benefits outweigh its risks for use in individuals, 16 years of age and older 17 members voted yes for voted against and one person abstained from voting. a final fda decision is expected within days they're going to look at what this advisory panel discovered and what they have approved and recommended and endorsed and then make a final decision but here's what we know about the vaccine, let's go through some of the key points right now it is given in 2 doses. weeks apart and result show it is 95% effective there are some side effects which includes sore arms and minor aches and pains. doctors in the uk reported that 2 vaccine recipients who both suffer from severe allergies did have allergic reactions to the vaccine. british regulators are now advising those with severe allergic reactions to avoid being vaccinated at this time. the pfizer vaccine must also be stored -94. degrees.

advisory panel f.d.a. says the advisory panel and chose a number of outlets temporarily just for this dose so yes i think within a very few days do you know it will approve this flies or maxine as the 1st us over the next scene the last 2 times vaccines were rushed into used in less than a year was $976.00 swine flu and 2009 swine flu and in both of those cases that seems to have severe cause severe reactions after they were used in a large number of people so that certainly could happen now because this is a very new vaccine we've never had a messenger on a vaccine before we have no idea really what the side effects will be over a period of time it's hard to know because these people were only followed for 2 months and reactions can occur a number of months down the road and right now it's not clear that didn't fly is a really want to look very hard for those long term reactions or lawmakers in new york have introduced a bill to make over vaccination mandatory sparking aprile the bill would require people

just in, an fda advisory panel giving the green light for the pfizer vaccine here in the u.s. the panel recommending emergency approval. scientists and doctors on the panel saying the fda should move forward. the vote a short time ago, 17-4. so, who were the four who voted against it and what we've learned tonight about their reason why. and a volunteer in pfizer's trial who reported mild side effects urging the fda to approve the vaccine now. the fda now makes the next move and it could come at any time. the first shipment of millimeters of doses ready to all 50 states within 24 hours of the final sign-off from the fda. fedex will take the west, u.p.s. will take the east. tonight in the uk, how this is working already. from the moment they take the vaccine out of those freezers, how much time do they have to administer the shot? and what it says about what we'll see here. and tonight, your questions. is the vaccine safe? what about those two reports of allergic reactions? dr. jha is here to answer your questions and to put this in perspective for us. >>> all of this comes as t

we knewed advise, outside advisory panel is not set to meet until december 10th. these things take time. if you talk to people at the fda who explain this. that, of course, has not been sufficient for president trump who long held a belief that scientists at the fda are, would go slowly to thwart him politically. a claim made before the election and one he's made since then that the fda denied. clearly, the fda thought this was going to be a tense meeting. putting out a statement last night to axios from commissioner hahn saying that it's not, he's not the one who makes this decision. the career scientists looking at data, going through it. they make the decision about whether or not one of these vaxzens can be used on an emergency basis. what would happen before that pool approval would be granted. so, of course, the white house doesn't seem to have a lot of options here, because it's not like they can be unhappy with the fda commissioner and fire him with six weeks left to go in the administration. many people do not think that would be a wise decision. though i

all eyes are on the fda advisory panel. they're meeting and voting as we speak. >> that's right, wolf. they just concluded the vote. the fda's independent advisory committee, they are recommending that the fda provide emergency use authorization for moderna's coronavirus vaccine. that was the full committee vote, 20 committee members voted yes. one person abstained. no one voted against this emergency use authorization. the next step is it goes back to the fda to make a decision about whether to grant that emergency use authorization. that could move relatively quickly. we doesn't know how quickly. the fda has looked a lot of this moderna vaccine and put out various recommendations before the independent met and discussed this vaccine and voted on it. we wait to hear the final word from the fda. we'll see another cdc meeting this weekend. after we get word from the fda, it won't be long that we see this vaccine going out to states as well. we know that the supply of vaccines has been extremely limited that's been getting ou

we start with that breaking news from an independent fda advisory panel of experts. late today giving its endorsement for emergency use of pfizer's covid vaccine here in the united states their recommendation now in the hands of the fda itself which could give its go-ahead any day now and that will start the beginning of a mass vaccination effort as the country reels from the loss of over 3,000 people in a single day from the virus. let's begin tonight with tom costello. >> reporter: the virtual vote came after eight hours of back and forth on efficacy and safety. an outside advisory panel of experts charged with giving the fda unbiased and unfiltered analysis of pfizer's covid vaccine. >> the american public demands and deserves a rigorous, comprehensive and independent review of the data. >> reporter: now the fda will decide whether to follow the uk and canada in green lighting the vaccine for emergency use. that decision could come within days or even hours. fda commissioner hahn on "today. >> we shrunk a process that normally takes months into one that has taken

just in, an fda advisory panel giving the green light for the pfizer vaccine here in the u.s. commending emergency approval. scientists and doctors on the panel saying the fda should move forward. the vote a short time ago, 17-4. so, who were the four who voted against it and what we've learned tonight about their reason why. and a volunteer in pfizer's trial who reported mild side effects also urging the fda to approve the vaccine now. the fda now makes the next move and it could come at any time. the first shipment of millions of doses ready to all 50 states within 24 hours of the final sign-off from the fda. fedex will take the west, u.p.s. will take the east. and tonight, in the uk, how this is working already, from the mome t

right now we have our eyes on an fda advisory panel meeting where moderna's covid vaccine is being pickedhealth experts. this is a major hurdle, the same panel that gave a

>>a major development in the fight against the pandemic to us advisory panel has endorsed the pfizer vaccine. setting the stage for final approval from the fda. thank you for joining us at 6 o'clock everybody i'm grant lotus and i'm vicki liviakis that decision could come as soon as tomorrow signaling the start of one of the largest vaccine distribution campaigns. >>in u.s. history. the advisory group voting 17 to 4 with one person abstaining from the vote. determining the shots are safe and effective for the american public. it comes as the u.s. has seen its last. 2 deadliest days in the pandemic with more than 3,000 deaths both yesterday and today in all nearly 300,000 americans have lost their lives state of california expected to get 327,000 doses of this pfizer vaccine which. >>well then be divvied up and shipped to county health departments and hospitals the bay area public health departments are expecting the first batch to arrive next tuesday. alameda county set to receive almost 14,000 doses. contra costa 10,000 both and napa counties likely to be given a little less than 20

at this hour an independent fda advisory panel meeting to decide whether to recommend emergency authorization for the pfizer vaccine. the final step before anticipated fda approval within days. >> i'm not going to prejudge what the advisory committee, which is a nonbinding committee of scientific experts, will say to us. we'll have to see what the scientific and medical discussion is today. but our plan is to take their recommendations into account for our decisionmaking and make a decision shortly thereafter. >> front line workers in hospitals across the country desperate for a vaccine to help turn the tide against covid-19. they're all watching today's meeting closely as we see the horrifying toll from this virus. a record 3,103 new covid-related deaths on wednesday alone and a record 225,000 positive cases in a 24-hour period. joining me now, nbc's morgan radford outside fda headquarters in maryland. nbc's steve patterson in phoenix. dr. kavita patel, former health policy director in the obama administration. and our own nbc senior medical correspondent dr. john torres. morgan, first to yo

the advisory panel that for about nine hours. they were incredibly thorough. they 17 yeas, four knows, and one abstention. during the debate they talked about potential side effects from a mild fever that lasted for about a day, also the debates over the age. some covid vaccines, nobody 18 and younger. this specific vaccine, the pfizer vaccine deals with 16 and 17-year-olds. that was an issue if the full fta career employees approve it, we could see vaccines going out in a few hours or days. the majority of americans won't be vaccinated until the spring, maybe early summer. >> that will get us on the road to being normal. as soon as we speak of the new normal will take some getting used to for americans who want to get on a plan plane. the largest airline trade association in the world is working on a mobile app that will show you are covid free and vaccinated before you build board a flight. >> this information is only kept by the customer, which is key. the customer shares with whomever they wish to share it with, and if they want to delete it, they delete i

government advisory panel has given a green light to the fires of vaccine regulators have been meeting to discuss the emergency use of the covert job and i've concluded the benefits outweigh the risks the u.k. warning people with severe allergies against taking the drug in america itself the food and drug administration has revealed 6 people died during its trials more guys the earth has more details. this was very very bad for publicity at a time when people are already nervous with all the rushed that scenes all the cut corners and now warnings any person with a history of a significant allergic reaction to a vaccine medicine or food should not receive the pfizer beyond vaccine how did they miss during clinical trials that people with severe allergies best stay the heck away from pfizer's vaccine was hardly a mere coincidence 2 british nurses went down with a severe reaction on the 1st day of public vaccination the question it begs is what outs that pfizer mean is that in addition to what we already knew that the vaccine can cause pain headaches fatigue fever swelling and potentially

government advisory panel gives a green light to the. safety warnings coming from. america itself. let's. deal with. this it's going to. over everyone after 15 years germany is a country that does not want to protect its borders against illegal immigration and instead imposing curfews and. a milestone birthday 15 years since it came. through from a decade of questioning more. from moscow thanks for joining us tonight on our teams a national. day welcomes program. u.s. government advisory panel has given the green light to the vaccine regulators the side of the benefits of the covert outweigh any risks though despite the u.k. warning people with severe allergies against taking the drug i did america itself the food and drug administration has revealed 6 people died during its trials. as the details. after a short period of inception from its trial to the results it appears that a coded 19 vaccine has now been approved by a panel from the u.s. food and drug administration the panel voted $17.00 to $4.00 with one abstention and it appears they are approving a coded 1000 vaccine from t

objective evidence to suggest that its travel campaign has led to recent outbreaks despite his advisory panelpposing trips from advisory hot spots be excluded. >> translator: as for how to deal with the campaign in places where infections are increasing, we'll consider the opinions of the government advisory panel and governors in the areas. we continue to make thorough efforts to prevent the spread of infection while appropriately operating the campaign. >> officials reported over 1,400 new cases across the country on monday. more than 149,000 people in japan have been infected since the pandemic began. over 2,100 people have died. >>> meanwhile, many foreigners in japan cannot return home due to the pandemic. japanese immigration authorities have temporarily allowed them to work part-time in the country as? are struggling financially. the immigration services agency put the measure into effect on tuesday. the latest step is aimed at about 21,000 non-japanese including those who came to japan for short-term stays or as technical trainees. the agency said many of them find themselves stranded

. >>> we are awaiting a vote any moment now by a cdc advisory panel that will recommend which groupshould be the first to get one of the coronavirus vaccines now in the pipeline. the need for them is growing more urgently by the day. more than 269,000 americans have now lost their lives to covid-19. the country is facing more than 13.6 million cases and almost 100,000 people are hospitalized in the u.s. right now and that is a new record. >>> let's get straight to the white house. our chief white house correspondent jim acosta is joining us right now. the attorney general bill barr is one of the most loyal members of the trump administration but now he is publicly breaking with the president on the president's baseless claims that the election was stolen from him. >> reporter: that's right. this may be the most significant official contradiction of president trump's cries he was cheated out of a second term so far. as you said, his loyal attorney general bill barr said federal prosecutors have not uncovered any voter fraud that is extensive enough to up-end the election's results. ba

the advisory panel that will determine who gets it after those people are prioritized. that advisory panel does not advise the fda here behind me but, instead, they advise the cdc. so there are still questions ahead of us as we expect to hear that authorization as early as today. peter? >> yeah, certainly a lot of questions. many of those answers we'll be able to provide over the course of this next hour. ellison, to you in michigan, what is the plan to distribute this vaccine once pfizer gets that official green light? will the movement just happen like that in a snap? >> hey, peter. once there is that official green light, we expect to start seeing trucks moving and leaving this facility within about 24 hours. from here, once they put the vaccines in those trucks, those extra cold freezing trucks, we expect them to then go to u.p.s. and fedex distribution centers in memphis and louisville. fed ex expected to handle the bulk of distribution of states west of the minneapolis. u.p.s. among states east of the mississippi. from there, each state has their own plan for dist

overnight, an fda advisory panel gave the green light to pfizer.the vaccine, formal approval by the fda could come as soon as this morning. even during our program. so we'll keep you posted. joining us now is dr. peter hotez, the dean of the national school of tropical medicine at bay hardware colle baylor college of medicine in houston. so dr. hotez, everybody is waiting to see what happens today and when americans can get vaccinated. and dr. fauci had said that if this all goes apace, you know, that things could return to normal as early as this summer or early fall. what do you think of that timeline? >> yeah, i think it's certainly possible, alisyn. first of all, it's good news today that the eua may be issued today, or even if it's not, early next week, that's just fabulous news. start rolling out the vaccine. and that will be the beginning of a long road to recovery. i think the timeline of summer/fall feeling like we're back to normal, yes, i think it's possible. a lot of stars will have to align. you know, we estimate with a group in new yo

in just hours, an fda advisory panel will review moderna's vaccine, meaning we could have a second vaccine authorized within days. overnight, a really interesting and promising development. it seems there is more of the pfizer vaccine in every vial than previously thought. medical workers were able to get more doses out of each vial, which means more people will be able to get vaccinated more quickly. >>> also breaking this morning, french president emmanuel macron has tested positive for coronavirus after experiencing symptoms. his office says he will isolate for seven days. we have a live report from paris with more details, coming up. back in the u.s., the highest profile vaccination yet is scheduled for tomorrow. the white house confirms that vice president mike pence plans to get his shot on camera tomorrow morning. cnn has learned that president-elect joe biden will get the vaccine next week. >>> but we begin in san francisco with cnn's dan simon, where a stay-at-home order goes into effect tonight. what's the situation on the ground, dan? >> reporter: alisyn, good morning. californi

the food and drug it administered -- and drug administration advisory panel is meeting to scrutinize e vaccine. many are hoping for emergency authorization as cases sore. the fda panel will consider two reports of allergic reactions to the vaccine in the u.k. this week. for more now, i would like to bring in the founding director of the epidemiology program at the university of delaware. she is a u.s. expert in novel and reemerging diseases. we know that the fda is expected to approve this biontech pfizer vaccine. how big of a turning point will this be for the u.s.? >> this is very important news but i think that too many are mistakenly believing this is going to end the pandemic. while the safety and efficacy profile of the vaccine look very good, the supply and distribution is going to be a challenge as will hesitancy to be vaccinated among some groups. brent: in your assessment, how long will it take for the pandemic to be under control if we do have vaccinations beginning? how long until we reached something like herd immunity echo -- like herd immunity? >> i think very few in th

the fda advisory panel agreed with the benefits of the moderna vaccine. and they say that it outweighed the risks. moderna says the efficacy rate for the vaccine is 94%. the panel's recommendation will now be sent to the fda which is expected to grant approval for the vaccine. and if the fda does give the go-ahead, millions of doses of the vaccine will be headed out and could begin being shipped by monday. this comes as hundreds of thousands of people are tested positive for coronavirus every day, and the daily death toll hit new highs. >> reporter: moderna's vaccine moving one step closer to joining the fight against covid-19. just like pfizer's vaccine, the fda makes the final decision whether to green-light moderna's formula. an authorization is likely after federal regulators confirmed the vacs eastbound's safety earlier vaccine's safety earlier this week. >> the fda waives the advice it receives when taking actions on medical products. >> reporter: some 5.9 million doses will be shipped out if authorized. another round of pfizer's vaccine will go out

the fda recommending approval at least an advisory panel recommending approval for emergency use of a covid vaccine in the u.s.. but the 17 to 4 vote. the group concluded that the shot appears to be safe and effective against the pandemic and people 16 and older. final and official fda approval is expected now within a day or so millions of shots would then be shipped to begin vaccinating health care workers and nursing home residents widespread access is not expected until spring or summer now that the fda advisory panel has approved pfizer's vaccine. there are so many questions pertaining to potential side effects and how ready this shot is you know they they did rush it is it safe is it ready to go now so we want to check in right now with ucsf infectious disease specialist. >>doctor, peter chin, hong a favorite of this program. he's looked at the data surrounding the vaccine. thank you so much for joining us again tonight, doctor doctor 10 hong we have a question from nelly and now he's question is much like the question i asked last hour but it's about you know at allergy patient

a key fda advisory panel just voted to recommend emergency use authorization for a second covid-19 vaccine here in the united states. this one from moderna. the nation now being hit by the pandemic like never before. with more than 310,000 deaths and 17.1 million confirmed cases. the daily death toll here in the u.s. soaring to a new high with nearly 4,000 lives lost in a 24-hour period. but the outgoing president is silent about the suffering, remaining checked out during a time of multiple emergencies, including a major russian cyberattack against the united states as well as the urgent need for economic relief to millions and millions of americans who are suffering right now. tonight, we're told congressional leaders are inching closer to a stimulus deal as another 885,000 americans had to file for first time jobless claims just last week. that's the highest level since early september. let's start off our coverage this hour with cnn's alexandra field with the breaking news on the fda advisory committee's vote. alexandra, moderna's vaccine is a major step closer and closer to being auth

who serves on the fda advisory panel which gave the green light a couple of hours ago. it is one step closer to the top tier of healthcare workers getting the vaccine, but there are many groups within that year that are going to still be waiting once the rollout begins. nurses and hospital workers are on the top tier to get vaccines as soon as pfizer ships out it's more than 6 million doses across country. >> i will take it with my hospital offering it to me. >> reporter: they will not even cover all hospital workers and long-term care facility staff. she is a pediatric infectious disease specialist and on the fda advisory panel giving the green light just hours ago. >> all of the data was incredibly compelling in terms of the efficacy, as well as the safety, and allowing the specimen to be used at this time. >> reporter: paramedics and dialysis centers are also into one will have to wait even longer than hospital workers. primary care clinics are in tier 2. further down the road, laboratory, dental and pharmacy staff in tier 3. >> i do hope that we will have a major im

how does the advisory panel balance these demands? >> well, what i would say, so a number of people have weighed in on these demands. the national academy of medicine put out their own guidance earlier this year. and the advisory committee on immunization practices, acip, very clearly uses an ethics framework to look at risks and benefits. in allocating what initially will be a small supply of vaccine that will grow every month. >> what about even more simple questions that i know folks have. like, will americans have a choice which vaccine they eventually take? is there a group of americans that should not get the vaccine? what about simple questions -- i don't know if they're simple questions, i guess there isn't one when it comes to vaccine distribution. do you expect that to come out from the panel today as well? >> i don't expect to hear that information specifically from the panel. we have two vaccines, as you know, that are going to the fda in very short order. the pfizer vaccine will be discussed by the fda on december 10th. t

the advisory panel has voted to approve the vaccine for use. give the official authorization. aren't you wondering why we are going to be third or fourth, given this pfizer vaccine the okay. do you think the bureaucrats are just waiting to look good, to look proven? that they are doing their job? do they work over thanksgiving? are they working saturday and sunday? people are dying at a record pace. >> greg: this is something as monumental as the moon shot. nothing like this has been done before. where leadership goes, points out at the bleachers and says okay, i'm going to hit it out there. and then what happens, he hits it out there. it's a grand slam in the world of invention, innovation and health. we shrunk the time it took to make a vaccine. we made three of them. it's really incredible. i think it's going to cement trump in history. all the people that hate him now, no one is going to remember those people. they are all going to be gone. all of his critics are going to be gone but this vaccine will be around forever. >> geraldo: that's w

happening at this hour, a cdc advisory panel with an emergency vote on that. that's at expected at 4:00. this is bob here from is st. joseph's university college. ashih shaw is also here with us. doctor, you start. who gets it first, how do we decide, where does it go first. >> well, if i were the people at the cdc, i would send the vaccine to the hotspots within the country first. i would certainly i'm you -- immunize the healthcare workers and doctors. and the question in the u.k., do we do the elderly and those at greatest risk above 70. my answer to that would be yes. so i could cover those two groups first. then i'd go from there to the paramedi paramedics, emts, healthcare workers, et cetera and bus drivers and et cetera and people handling our food. we have to keep them healthy. >> doctor, jump in here. how does it work, how do they make this decision in this ongoing meeting in atlanta right now? >> so bill, there's a few different things they're trying to factor in. right? they're trying to figure out who is essential that we have to protect right away

. >>> approval by fda advisory panel was a major milestone. a bay area scientist was on the panel. kiet do is joining us from alameda with more. >> reporter: good morning. yes, we are live in alameda over looking the coastguard island. the reason we are here is that when the vaccine shipments start coming in, this will be one of the first distribution sites as doses fan out across the area. on to the fda advisory panel, a pediatric infectious disease specialist at stanford is one of 22 experts who reviewed data and voted to approve. clinical trials showed pfizer nearly 95% effective for a dose 18 to 64 and juneteenth as effective for people of all ethnicities. some groups like people with weak immune systems, individuals with severe allergic reactions, pregnant women who were excluded from the trials could be restricted from getting the shot. >> all the data was incredibly compelling in terms of efficacy as well as safety in allowing this vaccine to be used at this time. not only are we in a pandemic and really need extraordinary strategy to get us so we can actually overcome this,

the fda could green light moderna's vaccine as early as today after an advisory panel recommended itor emergency use. it would join pfizer's vaccine, initially going to front line health workers and nursing home residents. the additional vaccine could not come quick enough as the number of coronavirus cases in the u.s. surpasses 17 million, with another 233,000 just yesterday. the state of california alone has seen more than 1,000 covid-related deaths in the past five days. debra alfarone is in washington now with the very latest on this. it looks like at least a little bit of good news. good morning. >> reporter: good morning, anne marie. you could call it the light at the end of a really long dark tunnel. this would mean that millions of people in rural and suburban areas are getting that much closer to getting a vaccine. >> looks like we have a favorable vote. >> reporter: an fda advisory panel is recommending moderna's coronavirus vaccine be authorized for emergency use. >> it looks like the benefits outweigh the risks from what i've seen. >> reporter: it comes one week after the

an fda advisory panel recommended the authorization thursday. it's the second vaccine recommendation in a week adding moderna's drug to the covid arsenal would pump millions of more doses into the supply chain and that could be critical in the days ahead. some states have been told to expect smaller than promised deliveries of the pfizer biontech vaccine beginning next week. cnn's dr. sanjay gupta explains how both the pfizer and moderna vaccines appear to work equally well. >> i think they're pretty similar from my standpoint. i would not, you know, sort of have a difference or a preference in terms of one or the other. i think for most people it's going to be a question of what you can get. i mean, right now, the demand is obviously much higher than the supply. the moderna vaccine will probably make its way into places maybe the pfizer couldn't because it doesn't require the same level of cold storage, so, you know, that's going to be a great option for people who live in those areas. other than that, i really don't draw a distinction between

an fda advisory panel is holding an all-day meeting right now. a vote will be held later today on weather to authorize the vaccine for emergency use in the united states. if it gets the okay, which is expected, the first americans could be vaccinated within days. this morning, a member of the advisory board laid out the significance of this meeting. >> today we will be considering whether to make available to millions of americans an as yet investigational vaccine that has been developed, tested and reviewed in record time. we will have a single question for the committee to vote on. the question is, based on the totality of scientific evidence available, do the benefits of the pfizer vaccine outweigh its risks for use in individuals 16 years of age and older. >> contrast this hope with the sad reality that the country just had the worse day in the history of the pandemic. the numbers really are staggering, more than 3,100 deaths were reported yesterday. the first time the nation has topped more than 3,000 deaths in a single day. since the start

in the meantime, the cdc has an advisory panel. it has put together additional ways in which this will be rolled out. healthcare workers will be at the top of the list. that is pretty clear as well as people who are living in and working in nursing homes. the next people in line would be those over 75, not 65 years old like we originally heard. also, next in line are front- line essential workers. here is how that panel of the cdc describes that. first responders, education, food and agriculture, manufacturing, postal service workers, public transit workers and grocery store workers. >> we need to get society moving again. essential functioning of the society is how they put it. >> reporter: one of the things about this new rollout are the vaccine is as a result of who is essential and who is not a front-line worker. this will help with the diversity issue because unfortunately, black and latino populations have been hit harder by the pandemic than other populations. this will hopefully even things out. reporting live in san franci

yesterday an fda advisory panel voted 17-4 to approve pfizer vaccine.a pediatric infectious disease specialist at stanford cast one of the votes. trials show the pfizer vaccine nearly 95% effective for adults 18 to 64 years old and as effective for people across all ethnicities. some groups like with weak immune systems or with severe allergic reactions and pregnant women were excluded from trials and can be restricted from getting the vaccine. >> i think the speed at which this happened is actually just really shows us what science can accomplish, not so much that this is different or was done in a way that made anything unsafe. it actual liv was done in a way that because there is huge scientific advantages. what was really remarkable is how there was collaboration throughout the scientific community that allowed this to be such a speedy progress. >> reporter: ups and fed ex will be shipping the vaccine. ups began shipping prep kits earlier in the week and they arrived yesterday at some hospitals. they have syringes, masks, a diluting agent for pfizer

. >>> tonight an fda advisory panel recommending emergency use authorization for a second coronavirus vaccine. this one manufactured by moderna. the fda says it plans to issue the authorization quickly. that as the u.s. is dealing with record rates of daily new cases, rising deaths, and record numbers of covid-19 patients in hospitals. president trump out of sight and silent on the crisis. one white house adviser saying trump's complaining about losing the election but his whining is unbecoming. and president-elect joe biden making history, picking the first native american as a cabinet secretary. i want to bring in now cnn's white house correspondent john harwood and cnn political analyst ron brownstein. good to see both of you. thank you for joining me. we've got a lot to talk about tonight. so john, the former governor of new jersey chris christie spoke to chris cuomo earlier and here is what he said about the election. >> whenever anybody loses an election, party, individual, there is great disappointment but elections have consequences and this one was clearly won by president-el

we will also get you an update on that fda advisory panel happening right now.hey should be very close to approving moderna's vaccine. we'll be right back. state-of-the-art but dependable. in other words, you want a hybrid. so do telcos. that's why they're going hybrid with ibm. a hybrid cloud approach with watson ai helps them roll out new innovations anywhere without losing speed. from telco to transportation, businesses are going with a smarter hybrid cloud, using the tools, platform and expertise of ibm. good work little buddy. ♪ ♪ i waited to get treated. thought surgery was my only option. but then i found out about nonsurgical treatments. it was a total game changer. learn more about the condition at factsonhand.com liz: the man dubbed the hollywood brandfather is ready for his next billion dollar idea. rohan oza is entering the spac world. last week, he took his special purpose acquisition or blank check company public on the nasdaq. this is his very first spac. he's the guy behind brands from kambucha to vitamin water to chef's cut, beef jerky, chicken

the fda usually follows the recommendation of the advisory panel, and so far they indicated they're going to give the pfizer vaccine a thumbs up. this hearing begins tomorrow morning, 6:00 a.m. our time. of course, we'll be following it. back to you guys. >> thank you. >>> we want to show you some breaking news in san jose now where police are involved in a standoff with a person in a safeway parking lot. it's happening at the safeway on the corner of brandon lane and camden road. police say the person is in a car and refusing to get out of that car. they believe the suspect is tied to a burglary ring that's targeting storage units. of course, we'll continue to monitor the situation. we'll bring you updates right here online and right here on the newscast as well. >>> up next at 6:00, a reversal that's really a great relief for kids and parents. the reason bay area playgrounds are now back open after being closed earlier this week. >>> okay, first the grinch came, now santa's helpers. we're going to put a bow on the story of some stolen bikes that were supposed to go to kids in the bay ar

advisory panel approved another covid vaccine. from moderna. key step that paves the way to distribute the second vaccine in the u.s. next up the decision will go to the fda. which follows the panel decision.

advisory panel thank you an honor to be on your show. who is of course has been a year since the 1st cases of corona virus were reported and scientists are still trying to work out exactly how the virus behaves the speedy development of vaccines is good news for most of us not so much for researchers who are trying to map the infection process mass immunity of course is going to make their jobs haga that's why one british research companies hoping to launch a study using human volunteers who willing to get infected the w.c. show that chelsea and pill reforms. just 18 years old allister's volunteering to do what many of us would find unimaginable he wants to be deliberately infected with the coronavirus he's campaigning to take part in a human challenge trial to test facts seems to cope with 19. chance charles have the potential to do an awful lot of good for an awful lot of people with. a significant minimal risk to myself and well it's a risk the docs and nurses take on pretty much every day like on the on the front lines of the pandemi

to lower poll diena germany's academic advisory panel to the government says this has to stop it has called for schools to go on their winter break early and for all non-essential shops to close now a full nationwide lockdown is looming in parliament on tuesday chancellor merkel made a passionate plea for all states to take immediate action. so how does how does deceive i know how much love gets poured into those christmas stands and i'm sorry from the bottom of my heart but if we have to pay the price of $590.00 people dying every day that's just not acceptable in my eyes and we must take x. and accept that they are just getting this is. the question seems to be whether germany's 16 states will impose more restrictions before all right after christmas by the way people are prepared for a different holiday season this year. live decided not to visit my grandparents sign i think it's better to make an effort to keep them safe. and it's not about how it feels it feels terrible for everyone but we have to get this under control somehow. daughter will only come for a short period of time

advisory panel thank you an honor to be on your show. who is close it's been a year since the 1st cases of corona virus were reported and scientists are still trying to work out exactly how the virus behaves the speedy development of vaccines is good news for most of us not so much for researchers who are trying to map the infection process mass immunity of course is going to make the head jumps haga that's why one british research companies hoping to launch a study using human volunteers who are willing to get infected u.w. shot at chelsea before it's. but just 18 years old allister's volunteering to do what many of his but find unimaginable he wants to be deliberately infected with the coronavirus he's campaigning to take part in a human challenge trial to test facts seems to cope with 19. chance charles have the potential to do an awful lot of good for an awful lot of people with. a significant a minimal risk myself and well it's a risk you know docs and nurses take on pretty much every day like on the on the frontlines of the pandemi

to lower poll diena germany's academic advisory panel to the government says this has to stop it has called for schools to go on their winter break early and for all non-essential shops to close now a full nationwide lockdown is looming in parliament on tuesday chancellor merkel made a passionate plea for all states to take immediate action. so how does his ass how does this see i know how much love gets poured into those christmas fans and i'm sorry from the bottom of my heart but if we have to pay the price of 590 people dying every day that's just not acceptable in my eyes and we must take x. and accept the player because this happened this is. the question seems to be whether germany's 16 states will impose more restrictions before all right after christmas by the way people are prepared for a different holiday season this year. i've decided not to visit my grandparents china i think it's better to make an effort to keep them safe. and it's not about how it feels it feels terrible for everyone but we have to get this under control somehow. so will only come for a short period of

chooses the advisory panel and chose a number of journalists temporarily just for this dose so f. the f.d.a. provides all the reading materials provides referrals except except for pfizer and so f.d.a. arranges the advisory committee meetings to go the way they plan the decision should go in almost every case so yes i think within a very few days deal they will approve this flies or vaccine as the 1st u.s. covert vaccine there are up to 100000000 doses that there's 2 doses. so that's up to 50000000 people could conceivably get it although many people have said they don't want to they don't want to be the 1st ones why should the beginning . what about those warnings coming from the u.k. the people who have severe out as you should avoid taking that vaccine i mean with other vaccines as far as i know there are also warnings that come with warning labels that people with certain conditions perhaps immunocompromised people shouldn't take them do you think we should be concerned about these these this results coming out of the u k. yes at the advisory committee meeting today it was sai

advisory panel.ll of it guaranteeing it will receive emergency approval by the f.d.a., possibly within hours. now, that decision will immediately set off a frantic nationwide operation by fedex and u.p.s. to get nearly three million doses of the pfizer vaccine to hospitals and drug stores, and to get shots in the arms of vulnerable americans. tonight's vote comes at the darkest and deadliest point in the pandemic right here in the u.s. over the past 24 hours more than 3,000 deaths from the virus have been reported across the country. think about it-- 3,000 american lives lost in a single day. that is larger than the death toll on 9/11. even more unimaginable, tonight the head of the c.d.c. says we should expect that many deaths in the u.s. every single day for the next three months. as we come on the air, new cases are being reported at record levels, with several major cities including san francisco within weeks of running out of i.c.u. beds. and with the virus seemingly spreading faster than ever,

>>and that concludes the vote we do have a table below the fda advisory panel voted in favor of approving pfizer's covid-19 vaccine. this after the fda heard hours of testimony thursday pfizer's senior vice president of clinical research and development told the fda the company hasn't found serious safety concerns was observed frequently it ensure along with others the state. she was working for the pfizer executive also said the side effects are usually mild to moderate and consistent with what's expected from a trial that involves many people who are older or have co-morbidities evan find a participant in the pfizer trial told the fda he believes he received the real vaccine experienced only mild side effects and has not contracted covid-19 in the 5 months since his first owes. >>after compelling reason not to authorize it. it's simply immoral and unethical to deny think the health care workers first responders who want it. >>nevada senator jacky rosen has a message for americans worrying the vaccine was developed to quickly we have to trust that the there's no ulterior motives of that'

taking us behind the curtain on the advisory panel. now, while you were speaking, president trump just tweeted on the moderna vaccine. he says it has been you approved. mow tear that vaccine -- moderna vaccine overwhelmingly approved, distribution to start immediately, the president just putting out the tweet. this is breaking news. moderna overwhelmingly approved writes the president. distribution to start immediately, president trump tweeting that out moments ago. coming up, 'tis the season to give. one tech startup is spreading holiday cheer by giving back this holiday season. we're going to take you there. you're watching "mornings with maria" live on fox business. to all the businesses that helped us make it through 2020... thank you for going the extra mile... and for the extra pump of caramel. thank you for the good food... and the good karma. thank you for all the deliveries... especially this one. you've reminded us that no matter what, we can always find a way to bounce forward. so thank you, to our customers and to businesse

that age requirement, aim madge, that's one of the most interesting things i found about the advisory paneldd fiezing the fda just yesterday. 77% of the experts who were on that panel said this vaccine is good to go. the rest either ab stained or voted no. they weren't voting no because they were necessarily saying the vaccine was not safe. instead, they were saying there wasn't enough data about that 16 and 17-year-old age group to give a whole hearted recommendation. of course, they were the minority of that panel. but that means that the fda has more options. when they offer that authorization, they could, for example, say we authorize it for people 18 and above. they could also take the committee's recommendation and say we authorize it for those 16 and above. they could ask more questions. for example, how long does that 95% effectiveness last? these are the kind of questions we're waiting to find out as we wait for that eminent possible fda approval and authorization. >> you raised good questions that we'll dig into over the course of the hour. gather, how is pfizer gearing up for the